227 related articles for article (PubMed ID: 18836037)
1. E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.
Rabinovich A; Jin VX; Rabinovich R; Xu X; Farnham PJ
Genome Res; 2008 Nov; 18(11):1763-77. PubMed ID: 18836037
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
Xu X; Bieda M; Jin VX; Rabinovich A; Oberley MJ; Green R; Farnham PJ
Genome Res; 2007 Nov; 17(11):1550-61. PubMed ID: 17908821
[TBL] [Abstract][Full Text] [Related]
3. The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation.
Lavrrar JL; Farnham PJ
J Biol Chem; 2004 Oct; 279(44):46343-9. PubMed ID: 15328355
[TBL] [Abstract][Full Text] [Related]
4. Use of chromatin immunoprecipitation to clone novel E2F target promoters.
Weinmann AS; Bartley SM; Zhang T; Zhang MQ; Farnham PJ
Mol Cell Biol; 2001 Oct; 21(20):6820-32. PubMed ID: 11564866
[TBL] [Abstract][Full Text] [Related]
5. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
7. ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene.
Kherrouche Z; Blais A; Ferreira E; De Launoit Y; Monté D
Biochem J; 2006 Jun; 396(3):547-56. PubMed ID: 16512785
[TBL] [Abstract][Full Text] [Related]
8. p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.
Truscott M; Harada R; Vadnais C; Robert F; Nepveu A
Mol Cell Biol; 2008 May; 28(10):3127-38. PubMed ID: 18347061
[TBL] [Abstract][Full Text] [Related]
9. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
10. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
[TBL] [Abstract][Full Text] [Related]
11. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
12. The identification of E2F1-specific target genes.
Wells J; Graveel CR; Bartley SM; Madore SJ; Farnham PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3890-5. PubMed ID: 11904439
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Pur-alpha promoter by E2F-1.
Darbinian N; White MK; Khalili K
J Cell Biochem; 2006 Nov; 99(4):1052-63. PubMed ID: 16741925
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomics on MCM8 orthologous genes reveals the transcriptional regulation by transcription factor E2F.
Hayashi R; Goto Y; Haga A; Kobayashi D; Ikeda R; Yoshida K
Gene; 2006 Feb; 367():126-34. PubMed ID: 16325355
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of the human Cdc2L1 gene promoter.
Kahle A; Feng Y; A Nelson M
Gene; 2005 Jan; 344():53-60. PubMed ID: 15656972
[TBL] [Abstract][Full Text] [Related]
18. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
Croxton R; Ma Y; Cress WD
Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
[TBL] [Abstract][Full Text] [Related]
19. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.
Bieda M; Xu X; Singer MA; Green R; Farnham PJ
Genome Res; 2006 May; 16(5):595-605. PubMed ID: 16606705
[TBL] [Abstract][Full Text] [Related]
20. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
